The ratios of CIC to CYFRA21-1, PrGIC to ProGRP, NGIC to NGAL, and NSIC to NSE were significantly higher in patients with NSCLC than in HCs (Figure 1E). This evidence concerns the gene ENO2 and non-small cell lung carcinoma.